PROCEPT BioRobotics Corp
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
PRCT$23.05+3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss F-
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except per share data)
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Revenue | $308,054 | $224,498 | $136,191 |
| Cost of sales | 111,828 | 87,399 | 65,142 |
| Gross profit | 196,226 | 137,099 | 71,049 |
| Operating expenses: | |||
| Research and development | 71,277 | 62,298 | 48,446 |
| Selling, general and administrative | 228,808 | 171,415 | 131,773 |
| Total operating expenses | 300,085 | 233,713 | 180,219 |
| Loss from operations | (103,859) | (96,614) | (109,170) |
| Interest expense | (3,586) | (4,184) | (3,995) |
| Interest and other income (expenses), net | 12,063 | 9,753 | 7,348 |
| Loss before income taxes | (95,382) | (91,045) | (105,817) |
| Provision for income taxes | 190 | 368 | 80 |
| Net loss | $(95,572) | $(91,413) | $(105,897) |
| Net loss per share, basic and diluted | $(1.72) | $(1.75) | $(2.24) |
| Weighted-average common shares used to | |||
| compute net loss per share attributable to | |||
| common shareholders, basic and diluted | 55,544 | 52,125 | 47,255 |
| Other comprehensive gain (loss): | |||
| Foreign currency translation adjustment | (77) | — | — |
| Unrealized gain on cash equivalents | — | 30 | 90 |
| Comprehensive loss | $(95,649) | $(91,383) | $(105,807) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.